- Home
- GVH vs NCNA Comparison
GVH vs NCNA Comparison
Compare GVH & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GVH | NCNA |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | Australia | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 7.6M |
| IPO Year | 2023 | 2017 |
Fundamental Metrics
Financial Performance| Metric | GVH | NCNA |
|---|---|---|
| Price | $3.22 | $3.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $80.00 | N/A |
| AVG Volume (30 Days) | 51.1K | ★ 56.0K |
| Earning Date | 09-09-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 11.95 | N/A |
| Revenue | ★ $21,878,867.00 | N/A |
| Revenue This Year | $141,706.20 | N/A |
| Revenue Next Year | $3.35 | N/A |
| P/E Ratio | $0.27 | ★ N/A |
| Revenue Growth | ★ 24.52 | N/A |
| 52 Week Low | $2.95 | $2.78 |
| 52 Week High | $364.00 | $330.00 |
Technical Indicators
Market Signals| Indicator | GVH | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 38.25 | 42.99 |
| Support Level | $2.95 | $3.30 |
| Resistance Level | $4.03 | $4.55 |
| Average True Range (ATR) | 0.30 | 0.27 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 19.41 | 22.40 |
Price Performance
Historical ComparisonAbout GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.